WO2022245849A3 - Supplements for supporting metabolic function - Google Patents

Supplements for supporting metabolic function Download PDF

Info

Publication number
WO2022245849A3
WO2022245849A3 PCT/US2022/029662 US2022029662W WO2022245849A3 WO 2022245849 A3 WO2022245849 A3 WO 2022245849A3 US 2022029662 W US2022029662 W US 2022029662W WO 2022245849 A3 WO2022245849 A3 WO 2022245849A3
Authority
WO
WIPO (PCT)
Prior art keywords
metabolic function
supplements
supporting
supporting metabolic
compositions
Prior art date
Application number
PCT/US2022/029662
Other languages
French (fr)
Other versions
WO2022245849A2 (en
Inventor
Guruduth S. Banavar
Hilary KEISER
Joshua Grant ANTOINE
Janelle CONNELL
Original Assignee
Viome Life Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viome Life Sciences, Inc. filed Critical Viome Life Sciences, Inc.
Publication of WO2022245849A2 publication Critical patent/WO2022245849A2/en
Publication of WO2022245849A3 publication Critical patent/WO2022245849A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided here are compositions that support metabolic function. The compositions comprise one or more of one or both of Berberine and White mulberry; Chromium; and one or both of B. lactis Postbiotic or B. longum BL-05. Citrus Flavonoids; Butyrate; Quebracho bark; Ginger Root Extract; Chamomile flower extract; and Curcumin.
PCT/US2022/029662 2021-05-17 2022-05-17 Supplements for supporting metabolic function WO2022245849A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163189566P 2021-05-17 2021-05-17
US63/189,566 2021-05-17

Publications (2)

Publication Number Publication Date
WO2022245849A2 WO2022245849A2 (en) 2022-11-24
WO2022245849A3 true WO2022245849A3 (en) 2022-12-29

Family

ID=84140979

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2022/029662 WO2022245849A2 (en) 2021-05-17 2022-05-17 Supplements for supporting metabolic function
PCT/US2022/029702 WO2022245875A1 (en) 2021-05-17 2022-05-17 Supplements for supporting mental health
PCT/US2022/029711 WO2022245882A1 (en) 2021-05-17 2022-05-17 Supplements for supporting gastrointestinal health

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2022/029702 WO2022245875A1 (en) 2021-05-17 2022-05-17 Supplements for supporting mental health
PCT/US2022/029711 WO2022245882A1 (en) 2021-05-17 2022-05-17 Supplements for supporting gastrointestinal health

Country Status (1)

Country Link
WO (3) WO2022245849A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101485748A (en) * 2009-02-20 2009-07-22 西南大学 Compound preparation of plant extract for treating diabetes
US9539247B2 (en) * 2014-11-28 2017-01-10 AKADEMY PHARMA S.r.L. Nutraceutical composition for the treatment of excess weight and moderate hypercholesterolemia/dysglycemia
WO2017008909A1 (en) * 2015-07-16 2017-01-19 Rottapharm S. P. A. Oral formulation comprising berberine and morus alba extract

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type
US20030206978A1 (en) * 2001-11-29 2003-11-06 Bob Sherwood Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
US8257694B2 (en) * 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
WO2012116445A1 (en) * 2011-02-28 2012-09-07 Technologies Khlôros Inc. Chewable vehicle for mouth absorption
EP3426273B1 (en) * 2016-03-11 2021-04-21 Harmonic Pharma Sublingual compositions comprising natural extracts and uses thereof
MX2020005777A (en) * 2017-12-06 2020-11-06 Lac2Biome S R L Composition based on probiotics and uses thereof.
US10517322B1 (en) * 2018-03-19 2019-12-31 Life Kitchen, LLC Dietary supplement formulations for promoting sleep
WO2020205676A1 (en) * 2019-03-29 2020-10-08 V Rush Vapes LLC Composition of athletic and fitness supplements, method for production and method for pulmonary administration of same
JP2022540096A (en) * 2019-07-02 2022-09-14 マイクロシンテシス インコーポレイテッド Quorum sensing inhibitors and/or postbiotic metabolites and related methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101485748A (en) * 2009-02-20 2009-07-22 西南大学 Compound preparation of plant extract for treating diabetes
US9539247B2 (en) * 2014-11-28 2017-01-10 AKADEMY PHARMA S.r.L. Nutraceutical composition for the treatment of excess weight and moderate hypercholesterolemia/dysglycemia
WO2017008909A1 (en) * 2015-07-16 2017-01-19 Rottapharm S. P. A. Oral formulation comprising berberine and morus alba extract

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KOPPEN LAURA M., WHITAKER ANDREA, ROSENE AUDREY, BECKETT ROBERT D.: "Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review", JOURNAL OF EVIDENCE-BASED COMPLEMENTARY & ALTERNATIVE MEDICINE, vol. 22, no. 4, 1 October 2017 (2017-10-01), pages 956 - 968, XP093021000, ISSN: 2156-5872, DOI: 10.1177/2156587216687695 *

Also Published As

Publication number Publication date
WO2022245875A1 (en) 2022-11-24
WO2022245849A2 (en) 2022-11-24
WO2022245882A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
Hou et al. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure–activity relationship and molecular mechanisms involved
Lee et al. Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo
AR048181A1 (en) COMPOSITION OF FUNCTIONAL INGREDIENTS
WO2012033634A3 (en) Topical skin care formulations comprising plant extracts
WO2006078699A3 (en) Oral care compositions derived from the labiatae family
MX2009007088A (en) Composition containing a quinoa grain extract for dematological use.
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
CO6280592A2 (en) A DRINK AND METHOD FOR PREPARATION
Herrera Herrera et al. Susceptibility of Porphyromonas gingivalis and Streptococcus mutans to Antibacterial Effect from Mammea americana
UA88165C2 (en) Use of trisubstituted benzopyranones
Ayo et al. Phytochemical screening and antimicrobial activity of three plants used in traditional medicine in Northern Nigeria
Maqsood et al. Preliminary phytochemical screening, antifungal and cytotoxic activities of leaves extract of Moringa oleifera Lam. from Salt range, Pakistan
BR112023026246A2 (en) MODIFICATION OF PLANT MESSENGER PACKAGES
WO2021090214A3 (en) Berberine compositions and their use
CL2008001685A1 (en) Antioxidant almond skin extract with a phenolic content greater than 5% containing procyanidins, propelargonidins and prodelphinidins; Extract preparation procedure: preparation of the plant material containing the skin, extraction of the skin with organic solvents, drying; applications.
EP3932485A4 (en) Composition containing plant-derived extract and/or plant-derived processed product
WO2022245849A3 (en) Supplements for supporting metabolic function
WO2019209228A3 (en) Solid oral compositions comprising dried honey and herbal extracts
EP3684389A4 (en) Isolation, preservation, compositions and uses of extracts from justicia plants
WO2021072450A3 (en) Novel nutrients to enhance load-induced muscle hypertrophy
WO2017160694A3 (en) Compositions for providing vitamin d to the skin
WO2021091805A3 (en) Plant extracts and methods for making and using the same
Tabatabaei Yazdi et al. Antifungal effect of aqueous and methanolic Avicennia marina leaves extracts on alternaria alternata and Penicillium citrinum
Choi et al. Physiological activities of Cudrania tricuspidata extracts (part I)
WO2011038472A8 (en) Standardized plant extract, method for preparing an extract from plants of the sclerolobium genus, cosmetic composition, pharmaceutical composition and use of said extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22805335

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22805335

Country of ref document: EP

Kind code of ref document: A2